199 related articles for article (PubMed ID: 1652209)
1. Role of cAMP-phosphodiesterase isozymes in pathogenesis of murine nephrogenic diabetes insipidus.
Homma S; Gapstur SM; Coffey A; Valtin H; Dousa TP
Am J Physiol; 1991 Aug; 261(2 Pt 2):F345-53. PubMed ID: 1652209
[TBL] [Abstract][Full Text] [Related]
2. High activity of low-Michaelis-Menten constant 3', 5'-cyclic adenosine monophosphate-phosphodiesterase isozymes in renal inner medulla of mice with hereditary nephrogenic diabetes insipidus.
Takeda S; Lin CT; Morgano PG; McIntyre SJ; Dousa TP
Endocrinology; 1991 Jul; 129(1):287-94. PubMed ID: 1647298
[TBL] [Abstract][Full Text] [Related]
3. Cellular action of vasopressin in medullary tubules of mice with hereditary nephrogenic diabetes insipidus.
Jackson BA; Edwards RM; Valtin H; Dousa TP
J Clin Invest; 1980 Jul; 66(1):110-22. PubMed ID: 6249843
[TBL] [Abstract][Full Text] [Related]
4. Induction of intramembranous particle clusters in mice with nephrogenic diabetes insipidus.
Coffey AK; O'Sullivan DJ; Homma S; Dousa TP; Valtin H
Am J Physiol; 1991 Oct; 261(4 Pt 2):F640-6. PubMed ID: 1656782
[TBL] [Abstract][Full Text] [Related]
5. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
Torphy TJ; Zhou HL; Burman M; Huang LB
Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
[TBL] [Abstract][Full Text] [Related]
6. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
[TBL] [Abstract][Full Text] [Related]
7. Cyclic 3',5'-nucleotide diesterases in dynamics of cAMP and cGMP in rat collecting duct cells.
Yamaki M; McIntyre S; Rassier ME; Schwartz JH; Dousa TP
Am J Physiol; 1992 Jun; 262(6 Pt 2):F957-64. PubMed ID: 1320333
[TBL] [Abstract][Full Text] [Related]
8. Localization of low-KM cAMP phosphodiesterase in rat nephron segments.
Yoshida I; Takeda S; Homma S; Kusano E; Asano Y
Kidney Blood Press Res; 1997; 20(5):307-11. PubMed ID: 9419046
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of nephrogenic diabetes insipidus due to chronic administration of lithium in rats.
Christensen S; Kusano E; Yusufi AN; Murayama N; Dousa TP
J Clin Invest; 1985 Jun; 75(6):1869-79. PubMed ID: 2989335
[TBL] [Abstract][Full Text] [Related]
10. ADH resistance of LLC-pk1 cells caused by overexpression of cAMP-phosphodiesterase type-IV.
Yamaki M; McIntyre S; Murphy JM; Swinnen JV; Conti M; Dousa TP
Kidney Int; 1993 Jun; 43(6):1286-97. PubMed ID: 8391097
[TBL] [Abstract][Full Text] [Related]
11. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
Torphy TJ; Cieslinski LB
Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
[TBL] [Abstract][Full Text] [Related]
12. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the activity of five adenosine-3',5'-monophosphate-degrading phosphodiesterase isozymes in the adult rat neocortex.
Sutor B; Mantell K; Bacher B
Neurosci Lett; 1998 Aug; 252(1):57-60. PubMed ID: 9756358
[TBL] [Abstract][Full Text] [Related]
14. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
Elks ML; Manganiello VC
Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
[TBL] [Abstract][Full Text] [Related]
15. Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney.
Dousa TP
Kidney Int; 1999 Jan; 55(1):29-62. PubMed ID: 9893113
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of nucleotides in distal nephron of mice with nephrogenic diabetes insipidus.
Kusano E; Yusufi AN; Murayama N; Braun-Werness J; Dousa TP
Am J Physiol; 1986 Jan; 250(1 Pt 2):F151-8. PubMed ID: 2417500
[TBL] [Abstract][Full Text] [Related]
17. Nephron distribution of total low Km cyclic AMP phosphodiesterase in mouse, rat and rabbit kidney.
Kusano E; Yoshida I; Takeda S; Homma S; Yusufi AN; Dousa TP; Asano Y
Tohoku J Exp Med; 2001 Mar; 193(3):207-20. PubMed ID: 11315768
[TBL] [Abstract][Full Text] [Related]
18. "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide.
Bellamy TC; Garthwaite J
Mol Pharmacol; 2001 Jan; 59(1):54-61. PubMed ID: 11125024
[TBL] [Abstract][Full Text] [Related]
19. Distinct profiles of phosphodiesterase isozymes in cultured cells derived from nonpigmented and pigmented ocular ciliary epithelium.
Bode DC; Hamel LT; Wax MB
J Pharmacol Exp Ther; 1993 Dec; 267(3):1286-91. PubMed ID: 8263791
[TBL] [Abstract][Full Text] [Related]
20. Causes of the urinary concentrating defect in mice with nephrogenic diabetes insipidus.
Valtin H; Coffey AK; O'Sullivan DJ; Homma S; Dousa TP
Physiol Bohemoslov; 1990; 39(1):103-11. PubMed ID: 2165265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
